1097 related articles for article (PubMed ID: 33719081)
1. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081
[TBL] [Abstract][Full Text] [Related]
2. Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
De-Miguel-Balsa E; Estevan-Ortega R; Sempere-Selva MT; Latour-Pérez J; Baeza-Román A; Moya-Martinez A; Ramos-Rincon JM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7151-7161. PubMed ID: 34859881
[TBL] [Abstract][Full Text] [Related]
3. Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
Elshafei MN; El-Bardissy A; Khalil A; Danjuma M; Mubasher M; Abubeker IY; Mohamed MFH
Eur J Clin Invest; 2021 Sep; 51(9):e13645. PubMed ID: 34185313
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Deftereos SG; Giannopoulos G; Vrachatis DA; Siasos GD; Giotaki SG; Gargalianos P; Metallidis S; Sianos G; Baltagiannis S; Panagopoulos P; Dolianitis K; Randou E; Syrigos K; Kotanidou A; Koulouris NG; Milionis H; Sipsas N; Gogos C; Tsoukalas G; Olympios CD; Tsagalou E; Migdalis I; Gerakari S; Angelidis C; Alexopoulos D; Davlouros P; Hahalis G; Kanonidis I; Katritsis D; Kolettis T; Manolis AS; Michalis L; Naka KK; Pyrgakis VN; Toutouzas KP; Triposkiadis F; Tsioufis K; Vavouranakis E; Martinèz-Dolz L; Reimers B; Stefanini GG; Cleman M; Goudevenos J; Tsiodras S; Tousoulis D; Iliodromitis E; Mehran R; Dangas G; Stefanadis C;
JAMA Netw Open; 2020 Jun; 3(6):e2013136. PubMed ID: 32579195
[TBL] [Abstract][Full Text] [Related]
6. Colchicine for the treatment of COVID-19.
Mikolajewska A; Fischer AL; Piechotta V; Mueller A; Metzendorf MI; Becker M; Dorando E; Pacheco RL; Martimbianco ALC; Riera R; Skoetz N; Stegemann M
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015045. PubMed ID: 34658014
[TBL] [Abstract][Full Text] [Related]
7. Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.
Zein AFMZ; Raffaello WM
Diabetes Metab Syndr; 2022 Feb; 16(2):102395. PubMed ID: 35078098
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
Elshafei MN; Khalil A; El-Bardissy A; Danjuma M; Ahmed MB; Mohamed MFH
Medicine (Baltimore); 2020 Sep; 99(36):e21911. PubMed ID: 32899023
[TBL] [Abstract][Full Text] [Related]
9. Colchicine and mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia: A systematic review, meta-analysis, and meta-regression.
Nawangsih EN; Kusmala YY; Rakhmat II; Handayani DR; Juliastuti H; Wibowo A; Lim MA; Pranata R
Int Immunopharmacol; 2021 Jul; 96():107723. PubMed ID: 34162130
[TBL] [Abstract][Full Text] [Related]
10. Dementia and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: A systematic review and meta-analysis.
Hariyanto TI; Putri C; Arisa J; Situmeang RFV; Kurniawan A
Arch Gerontol Geriatr; 2021; 93():104299. PubMed ID: 33285424
[TBL] [Abstract][Full Text] [Related]
11. Impact of colchicine on mortality and morbidity in COVID-19: a systematic review.
Sanghavi D; Bansal P; Kaur IP; Mughal MS; Keshavamurthy C; Cusick A; Schram J; Yarrarapu SNS; Giri AR; Kaur N; Moreno Franco P; Abril A; Aslam F
Ann Med; 2022 Dec; 54(1):775-789. PubMed ID: 35258357
[TBL] [Abstract][Full Text] [Related]
12. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.
Golpour M; Mousavi T; Alimohammadi M; Mosayebian A; Shiran M; Alizadeh Navaei R; Rafiei A
Int J Immunopathol Pharmacol; 2021; 35():20587384211031763. PubMed ID: 34250834
[TBL] [Abstract][Full Text] [Related]
13. Ivermectin for preventing and treating COVID-19.
Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
[TBL] [Abstract][Full Text] [Related]
14. Insulin Therapy and Outcome of Coronavirus Disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression.
Hariyanto TI; Lugito NPH; Yanto TA; Siregar JI; Kurniawan A
Endocr Metab Immune Disord Drug Targets; 2022; 22(5):481-489. PubMed ID: 34250875
[TBL] [Abstract][Full Text] [Related]
15. Colchicine use in patients with COVID-19: A systematic review and meta-analysis.
Chiu L; Lo CH; Shen M; Chiu N; Aggarwal R; Lee J; Choi YG; Lam H; Prsic EH; Chow R; Shin HJ
PLoS One; 2021; 16(12):e0261358. PubMed ID: 34962939
[TBL] [Abstract][Full Text] [Related]
16. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease may worsen outcomes from coronavirus disease 2019 (COVID-19) pneumonia in hospitalized patients: A systematic review, meta-analysis, and meta-regression.
Putri C; Hariyanto TI; Hananto JE; Christian K; Situmeang RFV; Kurniawan A
Parkinsonism Relat Disord; 2021 Jun; 87():155-161. PubMed ID: 33931304
[TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis.
Hariyanto TI; Kurniawan A
Sleep Med; 2021 Jun; 82():47-53. PubMed ID: 33892451
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.
Yasmin F; Najeeb H; Moeed A; Hassan W; Khatri M; Asghar MS; Naveed AK; Ullah W; Surani S
PLoS One; 2022; 17(4):e0266245. PubMed ID: 35381033
[TBL] [Abstract][Full Text] [Related]
20. The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Kow CS; Lee LH; Ramachandram DS; Hasan SS; Ming LC; Goh HP
Immun Inflamm Dis; 2022 Feb; 10(2):255-264. PubMed ID: 34970856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]